ResearcherJiangsu Province HospitalNo recent work listed

Wen Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8130-6073; OpenAlex author ID A5101450908. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2015: 1 paper

Papers 1

miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/onc.2014.101 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yulan Zhu · 1 shared paper, 2015 · strength 0.04
- Paper miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2014.101 ↗
Keiko Shinjo · 1 shared paper, 2015 · strength 0.04
- Paper miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2014.101 ↗
Yumei Gu · 1 shared paper, 2015 · strength 0.04
- Paper miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2014.101 ↗
Yi Miao · 1 shared paper, 2015 · strength 0.04
- Paper miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2014.101 ↗
Huihua Cai · 1 shared paper, 2015 · strength 0.04
- Paper miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2014.101 ↗
Min Tu · 1 shared paper, 2015 · strength 0.04
- Paper miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2014.101 ↗
Yutaka Kondo · 1 shared paper, 2015 · strength 0.04
- Paper miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. DOI 10.1038/onc.2014.101 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.